FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046469884> ?p ?o ?g. }

• W2046469884 endingPage "9885" @default.
• W2046469884 startingPage "9878" @default.
• W2046469884 abstract "The ability to exogenously impose targeted epigenetic changes in the genome represents an attractive route for the simulation of genomic de novo epigenetic events characteristic of some diseases and for the study of their downstream effects and also provides a potential therapeutic approach for the heritable repression of selected genes. Here we demonstrate for the first time the ability of zinc finger peptides to deliver DNA cytosine methylation in vivo to a genomic integrated target promoter when expressed as fusions with a mutant prokaryotic DNA cytosine methyltransferase enzyme, thus mimicking cellular genomic de novo methylation events and allowing a direct analysis of the mechanics of de novo DNA methylation-mediated gene silencing at a genomic locus. We show that targeted methylation leads to gene silencing via the initiation of a repressive chromatin signature at the targeted genomic locus. This repression is maintained after the loss of targeted methyltransferase enzyme from the cell, confirming epigenetic maintenance purely through the action of cellular enzymes. The inherited DNA methylation pattern is restricted only to targeted sites, suggesting that the establishment of repressive chromatin structure does not drive further de novo DNA methylation in this system. As well as demonstrating the potential of these enzymes as tools for the exogenous, heritable control of cellular gene expression, this work also provides the most definitive confirmation to date for a transcriptionally repressive role for de novo DNA methylation in the cell and lends some weight to the hypothesis that the aberrant methylation associated with certain diseases may well be a cause rather than a consequence of transcriptional gene repression. The ability to exogenously impose targeted epigenetic changes in the genome represents an attractive route for the simulation of genomic de novo epigenetic events characteristic of some diseases and for the study of their downstream effects and also provides a potential therapeutic approach for the heritable repression of selected genes. Here we demonstrate for the first time the ability of zinc finger peptides to deliver DNA cytosine methylation in vivo to a genomic integrated target promoter when expressed as fusions with a mutant prokaryotic DNA cytosine methyltransferase enzyme, thus mimicking cellular genomic de novo methylation events and allowing a direct analysis of the mechanics of de novo DNA methylation-mediated gene silencing at a genomic locus. We show that targeted methylation leads to gene silencing via the initiation of a repressive chromatin signature at the targeted genomic locus. This repression is maintained after the loss of targeted methyltransferase enzyme from the cell, confirming epigenetic maintenance purely through the action of cellular enzymes. The inherited DNA methylation pattern is restricted only to targeted sites, suggesting that the establishment of repressive chromatin structure does not drive further de novo DNA methylation in this system. As well as demonstrating the potential of these enzymes as tools for the exogenous, heritable control of cellular gene expression, this work also provides the most definitive confirmation to date for a transcriptionally repressive role for de novo DNA methylation in the cell and lends some weight to the hypothesis that the aberrant methylation associated with certain diseases may well be a cause rather than a consequence of transcriptional gene repression. Hypermethylation at CpG sequences is commonly observed in the promoters of a number of genes in cancer and is often associated with transcriptional down-regulation (reviewed in Ref. 1Baylin S.B. Nat. Clin. Pract. Oncol. 2005; 2: S4-S11Crossref PubMed Scopus (943) Google Scholar); however, whether such patterns of DNA methylation are the end result, or the initiating cause, of gene shutdown is a longstanding question (2Baylin S. Bestor T.H. Cancer Cell. 2002; 1: 299-305Abstract Full Text Full Text PDF PubMed Scopus (247) Google Scholar). The observed increases in levels of de novo methylation over time associated with some diseases, such as chronic myeloid leukemia and the progression from myelodysplastic syndrome to acute myeloid leukemia (3Zion M. Ben-Yehuda D. Avraham A. Cohen O. Wetzler M. Melloul D. Ben-Neriah Y. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 10722-10726Crossref PubMed Scopus (106) Google Scholar, 4Quesnel B. Guillerm G. Vereecque R. Wattel E. Preudhomme C. Bauters F. Vanrumbeke M. Fenaux P. Blood. 1998; 91: 2985-2990Crossref PubMed Google Scholar), might suggest a potentially more passive role for DNA methylation in these arenas, especially as a number of the genes seen to be aberrantly methylated in leukemia and cancer are sometimes similarly methylated in aging healthy cells. However, the ability to study the characteristics and consequences of such de novo methylation has been limited by the inability to simulate this event in vivo. The only direct route currently available for the authentic delivery of de novo DNA methylation is the use of gene-targeted DNA cytosine methyltransferase (Mtase) 2The abbreviations used are:MtasemethyltransferaseFHF38H mutantCATchloramphenicol acetyltransferaseEMSAelectrophoretic mobility shift assay. enzymes. These enzymes comprise fusions of gene-specific DNA-binding proteins, e.g. rationally designed zinc finger proteins, with DNA cytosine methyltransferases. The ability to design zinc finger proteins to recognize virtually any DNA sequence using well established zinc finger/DNA recognition codes or to select zinc fingers specific for a particular DNA sequence via phage display strategies has enabled the evolution of a number of novel proteins with cellular function. These include gene-specific transcriptional activators and repressors as well as targeted restriction enzymes capable of gene modification in vivo (5Jamieson A.C. Miller J.C. Pabo C.O. Nat. Rev. Drug Discov. 2003; 2: 361-368Crossref PubMed Scopus (227) Google Scholar, 6Lombardo A. Genovese P. Beausejour C.M. Colleoni S. Lee Y.L. Kim K.A. Ando D. Urnov F.D. Galli C. Gregory P.D. Holmes M.C. Naldini L. Nat. Biotechnol. 2007; 25: 1298-1306Crossref PubMed Scopus (739) Google Scholar). Following the initial demonstration of in vitro functionality of targeted cytosine methyltransferase enzymes (7Xu G.L. Bestor T.H. Nat. Genet. 1997; 17: 376-378Crossref PubMed Scopus (124) Google Scholar), they have since been shown to be capable of delivering targeted methylation in bacteria, yeast, and the mammalian mitochondrial compartment (8McNamara A.R. Hurd P.J. Smith A.E. Ford K.G. Nucleic Acids Res. 2002; 30: 3818-3830Crossref PubMed Scopus (56) Google Scholar, 9Carvin C.D. Parr R.D. Kladde M.P. Nucleic Acids Res. 2003; 31: 6493-6501Crossref PubMed Scopus (63) Google Scholar, 10Minczuk M. Papworth M.A. Kolasinska P. Murphy M.P. Klug A. Proc. Natl. Acad. Sci. U. S. A. 2006; 103: 19689-19694Crossref PubMed Scopus (128) Google Scholar) as well as inducing gene repression of plasmid-based reporter genes and viral vectors in transient assays (11Li F. Papworth M. Minczuk M. Rohde C. Zhang Y. Ragozin S. Jeltsch A. Nucleic Acids Res. 2007; 35: 100-112Crossref PubMed Scopus (110) Google Scholar). One potential problem with these enzymes has been the level of associated nontargeted methylation, which is sometimes unacceptably high due to the avidity of the wild-type Mtase components used and is often overlooked. Recently we showed that, employing four zinc finger arrays capable of binding to chromatin target sites (12McNamara A.R. Ford K.G. Nucleic Acids Res. 2000; 228: 4865-4872Crossref Scopus (14) Google Scholar, 13Smith A.E. Farzaneh F. Ford K.G. Biol. Chem. 2005; 2386: 95-99Crossref Scopus (3) Google Scholar) in combination with reduced affinity/activity prokaryotic DNA cytosine methyltransferase mutants, methylation could be targeted to predetermined sequences with virtually no nonspecific methylation occurring (14Smith A.E. Ford K.G. Nucleic Acids Res. 2007; 35: 740-754Crossref PubMed Scopus (44) Google Scholar). The HpaII methyltransferase F38H mutant used in these latter studies (henceforth referred to as FH) demonstrated a significantly overall reduced methyltransferase activity relative to the wild-type enzyme because of a mutation in the conserved FXGXG motif involved in Mtase cofactor binding and target base interaction, which allowed the zinc finger protein component to dominate in DNA-protein interactions. The use of non-mammalian Mtases as fusion components, additionally, was thought to be more likely to reduce any potential interactions arising with regulatory cellular factors, such as has been shown to occur with the endogenous DNMT3A and DNMT3B Mtases (15Hermann A. Gowher H. Jeltsch A. CMLS Cell. Mol. Life Sci. 2004; 61: 2571-2587Crossref PubMed Scopus (434) Google Scholar, 16Spada F. Li F. Papworth M. Minczuk M. Rohde C. Zhang Y. Ragozin S. Jeltsch A. Adv. Enzyme Regul. 2006; 46: 224-234Crossref PubMed Scopus (21) Google Scholar) and which might result in the mistargeting of Mtase activity in vivo. methyltransferase F38H mutant chloramphenicol acetyltransferase electrophoretic mobility shift assay. To examine the applicability of targeted methylation in modulating gene expression in the context of mammalian genomic DNA generally and as a prelude to targeting more functionally complex endogenous promoters, we have transiently expressed four zinc finger/HpaII (FH)-based Mtases in cells harboring an integrated reporter gene in which expression is driven by a minimal promoter flanked with a high density of HpaII sites (5′-CCGG-3′) immediately adjacent to zinc finger recognition sites. The short- and longer-term consequences of transient expression of targeted DNA methyltransferases on the appearance of de novo DNA methylation patterns, gene expression levels, modulation of chromatin marks, and epigenetic inheritance were subsequently examined. Tissue Culture and CAT Analysis—NIH3T3 cells were stably transfected with a CAT reporter gene target construct based on pBLCAT (39Luckow B. Schultz G. Nucleic Acids Res. 1987; 105: 5490Crossref Scopus (1401) Google Scholar) as described previously (14Smith A.E. Ford K.G. Nucleic Acids Res. 2007; 35: 740-754Crossref PubMed Scopus (44) Google Scholar). Clonal cell lines with demonstrated CAT activity were transiently transfected using the Nucleofector system (Amaxa GmbH) at an average of 80% efficiency, confirmed by green fluorescent protein/fluorescence-activated cell sorter analysis. Internal control β-galactosidase activity was assessed 48 h post-transfection to confirm equivalent transfection efficiencies within each experiment. CAT assays involved monitoring the level of acetyl transfer groups into 14C-labeled chloramphenicol resolved via TLC (Polygram™ SIL-G) and subsequently exposing the chromatogram to an imaging plate (Fuji), performed as described previously (13Smith A.E. Farzaneh F. Ford K.G. Biol. Chem. 2005; 2386: 95-99Crossref Scopus (3) Google Scholar). Methylation Analysis—Isolated genomic DNA was subjected to bisulfite modification using the EpiTect bisulfite kit (Qiagen Ltd.) according to the manufacturer's instructions. DNA corresponding to the target site and flanking regions was amplified using nested PCR with two different sets of primers for comparative purposes to conclusively demonstrate that PCR amplification was not biased toward methylated sequences. Primers were designed to bind 200–300 bp flanking the target site and thymidine kinase promoter regions, embedded in the pBLCAT vector. The modified vector sequence is available on request. Primers (5′-3′) used were as follows: Set 1, TargF1 (-ggtattagagtagattgtattgagtg), TargR1 (-ctatcccatatcaccaactcaccatcttc), TargF2 (-ggatgtgttgtaagg(c/t)gattaagttggg), and TargR2 (-caactaactaaaatacctcaaaatattc); and Set 2, TargF1 (-gagtaattgttgggaagg), TargR1 (-acaactaactaaaatacctcaaaatattct), TargF2 (-aagggggatgtgttgtaag), and TargR2 (-ttctccattttaacttccttaact). These primer sets gave equivalent results in terms of methylation trends for cloned products. Nested primer sets used for downstream CAT gene methylation analysis were CATF1 (-tttttaggagttaaggaagttaaaatggag), CATR1 (-ttccaccactactcccattcatcaattc), CATF2 (-aagaatatttgaggtattttagtt), and CATR2 (-tatcacaccacaaaaataaaattccttcac). Measurement of Targeted Mtase Levels—Time-dependent expression of targeted Mtases in NIH3T3 cells containing the integrated target site was monitored via both Western blot and reverse transcription-PCR analyses. Western blot analysis was performed essentially as described previously (14Smith A.E. Ford K.G. Nucleic Acids Res. 2007; 35: 740-754Crossref PubMed Scopus (44) Google Scholar). FLAG antibody (F1804) was from Sigma, and phosphorylated Rb antibody (Ser-807/811; 93085) was from Cell Signaling Technology. Western blot analysis of targeted enzyme (4aZf-FH) expression over time involved overexposure (30 min) to film (via ECL assay) to ensure maximum detection. Reverse transcription-PCR, used to more accurately determine the loss of expression of targeted Mtases from target cells over time, was performed as described previously (14Smith A.E. Ford K.G. Nucleic Acids Res. 2007; 35: 740-754Crossref PubMed Scopus (44) Google Scholar). EMSA Analysis—EMSA analysis used whole cell extracts derived from COS-1 cells transformed with relevant targeted Mtase expression constructs. EMSA probes used were representative of the target site used in targeted methylation experiments in vivo: 4aZf-CpG, 5′-ccggccggcaaggcttctgcgtcttccggcgccggcgccggccggcgccggccgg-3′; and 4bZf-CpG, 5′-ccggccggcaagagcgccgcgtcttccggcgccggcgccggccggcgccggccgg-3′. Zinc finger recognition sites are in bold, and HpaII sites are underlined. Bacterial ex vivo and in vivo methylation assays were performed as described previously and essentially involved either incubation of purified recombinant targeted/nontargeted HpaII Mtase with plasmids harboring a targetable site but with a background of nontargeted sites, followed by HpaII restriction of plasmid DNA, or restriction of plasmids purified from bacteria that were cotransformed with expression and target site vectors, respectively. Chromatin Immunoprecipitation Assays—Chromatin immunoprecipitation assays were performed essentially as described previously (40Cuthbert G.L. Daujat S. Snowden A.W. Erdjument-Bromage H. Hagiwara T. Yamada M. Schneider R. Gregory P.D. Tempst P. Bannister A.J. Kouzarides T. Cell. 2004; 118: 545-553Abstract Full Text Full Text PDF PubMed Scopus (667) Google Scholar). Antibodies against histone H3K4me3 (ab8580) and H3K9me2 (ab1220) were from Abcam (Cambridge, UK). Primers used for TaqMan analysis of immunoprecipitated chromatin fragments were F1 (5′-gcagcgacccgcttaaca-3′), R1 (5′-cctgaaaatctgccaagct-3′), and TAM (5′-caacagcgtgccgcagatc-3′). De Novo Methylation of a Genomic Target Site—We constructed a clonal cell line containing a single integrated CAT reporter gene driven by a minimal thymidine kinase promoter, modified to contain 4aZf recognition sites (5′-GACGCAGAAGCC-3′) flanked by a high density of target HpaII sites and a low density of HhaI (5′-GCGC-3′) and CG sites. This distribution of sequences allowed us to discriminate between purely targeted methylation by the targeted HpaII enzyme (4aZf-FH) and the action of endogenous Mtases, which could potentially methylate at these additional embedded HhaI and CpG sites and at flanking CpG sites. The 4aZf protein is a derivative of the well characterized anti-p190Bcr-Abl three-zinc finger protein (17Choo Y. Sánchez-García I. Klug A. Nature. 1994; 372: 642-645Crossref PubMed Scopus (246) Google Scholar) modified by a single zinc finger extension (12McNamara A.R. Ford K.G. Nucleic Acids Res. 2000; 228: 4865-4872Crossref Scopus (14) Google Scholar, 13Smith A.E. Farzaneh F. Ford K.G. Biol. Chem. 2005; 2386: 95-99Crossref Scopus (3) Google Scholar). Zinc finger peptides were expressed as N-terminal fusions with the HpaII (FH) mutant Mtase and were linked by a flexible linker (Gly4Ser)3. For a schematic of the proposed Mtase action and a more detailed description of the target site, see Fig. 1, A and B. In vitro DNA binding and methylation analysis confirmed specific targeted methylation within a complex DNA population (supplemental Fig. S1, A and B) (14Smith A.E. Ford K.G. Nucleic Acids Res. 2007; 35: 740-754Crossref PubMed Scopus (44) Google Scholar) and that tethering of the Mtase component at the zinc finger recognition site allows site-specific binding and targeted methylation to occur up to 40–45 bp away from the zinc finger site (supplemental Fig. S1D). Cells were transiently transfected at a high efficiency with 4aZf-FH or control constructs including ΔZf-FH, 4aZf alone, and 4bZf-FH (for a vector schematic, see Fig. 1C). The 4bZf-FH enzyme served as a control for any background methylation mediated via nonspecific zinc finger/methyltransferase-DNA interactions because the target region lacks 4bZf recognition sites (5′-GACGCGGCGCTC-3′). Isoschizomer restriction analysis (comparing restriction patterns generated by methylation-sensitive versus -insensitive restriction enzymes with the same sequence specificity) of plasmids coding for the 4aZf-FH and 4bZf-FH enzymes revealed similar levels of enzyme activity in bacteria, although these high copy number plasmids were seen to possess a low level of nonspecific methylation (supplemental Fig. S1C). Low copy number plasmids expressing these enzymes remained largely unmethylated. This effect of high cellular protein concentrations “overriding” the intrinsic specificity of zinc finger proteins has been reported previously by ourselves and others (13Smith A.E. Farzaneh F. Ford K.G. Biol. Chem. 2005; 2386: 95-99Crossref Scopus (3) Google Scholar, 18Choo Y. Castellanos A. Garcia-Hernandez B. Sanchez G. Klug A. J. Mol. Biol. 1997; 273: 525-532Crossref PubMed Scopus (48) Google Scholar) and demonstrates the need for moderate levels of such targeted Mtase enzymes in cellular systems. The ΔZf-FH (zinc finger deletion) construct represented an additional control for monitoring any untargeted methylation due solely to mutant methyltransferase activity at the target region. Transfection with wild-type HpaII or 4aZf-HpaII Mtase constructs ultimately proved toxic to the cell over the time scale of the experiments and was not studied further, confirming the requirement for mutational approaches in the development of these targeted Mtase enzymes. Western blot analysis confirmed equivalent expression levels for constructs used (Fig. 2A). EMSA analysis using whole cell extracts also confirmed that cellularly expressed 4aZf-FH protein bound significantly only to DNA containing 4aZf with multiple flanking HpaII recognition sites, but not to probe containing just multiple HpaII sites (Fig. 2B). Similarly, the 4bZf-FH protein bound only to probe containing the 12-bp 4bZf and multiple HpaII sites, albeit less strongly than 4aZf-FH to its target site. EMSA for the weakly binding 4bZf-FH protein at relatively higher protein levels is also shown to more clearly confirm specific binding to its target probe (Fig. 2B, inset). More detailed analysis of the binding and methylation of these proteins is given elsewhere, both describing the ability of the 4aZf-FH enzyme to target methylation specifically in the context of complex genomes in in vitro assays and demonstrating similar general enzymatic activities between the 4aZf-FH and 4bZf-FH enzymes (supplemental Fig. S1) (14Smith A.E. Ford K.G. Nucleic Acids Res. 2007; 35: 740-754Crossref PubMed Scopus (44) Google Scholar). To determine the extent of any targeted DNA methylation, genomic DNA was isolated 16 days post-transfection with various constructs, and methylation status was assessed initially by BsiEI restriction of post-bisulfite-modified DNA (COBRA assay) (19Xiong Z. Laird P.W. Nucleic Acids Res. 1997; 25: 2532-2534Crossref PubMed Scopus (1041) Google Scholar), sites for which are preserved through methylation of consecutive HpaII sites within the target sequence (Fig. 3A). Significant target site DNA methylation was associated with 4aZf-FH-transfected cells only, indicated by the observed cleavage of the PCR product (Fig. 3B, arrow), but not for 4bZf-FH- and ΔZf-FH-transfected cells, confirming target-specific methylation by the 4aZf-FH enzyme. Importantly and as a prerequisite to the further studies described in this work, the target site itself was not subject to de novo methylation by the endogenous Mtases of the cell. However, this may be a consequence of selecting clonal cell lines with a demonstrable reporter gene activity and hence a reduced likelihood of being the subject of cellular de novo methylation because methylated genes are more likely to be inactive. Clonal bisulfite sequencing analysis of the DNA methylation status of the target and flanking regions from independent experiments at an earlier time point (12 days post-transfection) (Fig. 3C) revealed significant target region methylation only after exposure to 4aZf-FH (49% of HpaII sites methylated) compared with 4bZf-FH (6.2%) and 4aZf protein or empty vector (2.1%). The low level of non-HpaII methylation observed at the target site after 4aZf-FH expression (1.7%) was the same level seen for control experiments and represents the normal background action of endogenous Mtases. No significant methylation spread, i.e. to non-HpaII sites in flanking sequences, was detected. Methylation analysis of a region comprising three additional downstream zinc finger recognition sites, which were flanked solely by non-HpaII CpG sites and which served as an internal control for the potential effects of endogenous cellular proteins interacting with the HpaII Mtase component of the targeted enzyme, revealed no significant methylation in this region. We have shown previously that the 4aZf-FH enzyme produces virtually no background methylation, even when expressed in the presence of the reasonably complex bacterial genome (14Smith A.E. Ford K.G. Nucleic Acids Res. 2007; 35: 740-754Crossref PubMed Scopus (44) Google Scholar). To further confirm that the low nontargeted activity of this enzyme was maintained in mammalian cells, we examined the methylation status of a cluster of HpaII sites in the body of the CAT gene, around 470 bp downstream from the target region (Fig. 3C, right panel). This analysis revealed no significant differences between control and 4aZf-FH-based experiments, confirming a lack of nonspecific action by targeted enzymes. Other attempts to identify possible nonspecific global DNA methylation as a result of targeted enzyme expression, e.g. via arbitrary-primed PCR approaches (20Liang G. Gonzalgo M.L. Salem C. Jones P.A. Methods (San Diego). 2002; 27: 150-155Crossref PubMed Scopus (60) Google Scholar) or random bisulfite sequencing, revealed no obvious changes in methylation (data not shown). However, we suggest that attempting to detect low level stochastic events against the background of relatively high endogenous methylation throughout the genome is impractical as well as ultimately uninformative. Our inability to detect any significant methylation at the target site, which has a high density of HpaII sites, following expression of the nontargeted HpaII Mtase enzyme ΔZf-FH (Fig. 3B), for example, tends to support our conclusion that off-target methylation by the targeted Mtase enzyme itself would be too low to be readily detectable. Cellular Maintenance of the Directed de Novo Methylation Pattern—Previous experiments describe a persistent methylation pattern over time, predominantly at HpaII sites within the target region. To eliminate the contribution of sustained targeted methylation as a route for maintaining this epigenetic pattern, for example through the persistence of an extraordinarily stable protein structure, we performed Western blot analysis of targeted cells transiently transfected with the 4aZf-FH expression vector and monitored protein concentration over time (Fig. 4A). It can be seen that there is a rapid fall-off in protein expression from day 2, and after 6 days no evidence of 4aZf-FH expression remains, even after the overexposure shown in the figure. This correlates with the expected loss of expression vector from the cell following transient transfection over time. A more sensitive reverse transcription-PCR analysis, which can detect levels of RNA transcripts that would not necessarily give rise to detectable protein levels in Western blot analyses, also confirmed that at 7 days post-transient transfection, 4aZf-FH expression is undetectable (Fig. 4B). These two points taken together imply that an initial de novo methylation pattern, laid down by the transient action of the targeted Mtase, is being maintained by the cell. Importantly, this also demonstrates that the cell does not differentiate exogenously from endogenously derived de novo methylation patterns and, in concert with the observation that methylation is predominantly restricted to HpaII sites at the target region, that the exogenous methylation pattern is not maintained via an “overwriting” mechanism where specific input methylation patterns would be lost. Targeted Promoter Methylation Induces Heritable Gene Repression—The effect of directed de novo methylation on gene expression was measured after 6, 12, and 24 days, together with target region methylation status over the same time period as assessed by combined bisulfite restriction analysis assay. Expression of the 4aZf-FH enzyme resulted in a nearly 70% drop in CAT activity compared with controls (Fig. 5A) and correlated with the observed high levels of methylation at the target site (Fig. 5B). Significantly, this repression could be partially alleviated by treatment of cells with the DNA-demethylating agent 5-azacytidine or the histone deacetylase inhibitor MS275 and further alleviated by cotreatment with these drugs to a level above that of normal gene expression (see supplemental Fig. S1). A weak alleviation of repression over time was observed for 4aZf-FH-transfected cells, which was mirrored by a similar slight fall in methylation levels observed at the target site (Fig. 5B). This effect may be due to a gradual loss of maintenance methylation or an outgrowth of untransfected cells over multiple passages. Expression of the 4bZf-FH enzyme resulted in an initial drop in CAT activity of about 20% at day 6 but returned to control levels by day 12. This observation of low level methylation by the 4bZf-FH protein was attributed to low density and transient nonspecific methylation, which may have been below the threshold for maintenance and perhaps working in concert with the effects of transient promoter occupancy by the enzyme. The suggestion that the 4bZf zinc finger component is not able to fully suppress nonspecific methylation by the Mtase component is in line with the relatively weak binding of the 4bZf-FH enzyme to its target site (Fig. 2B). Zinc finger protein binding alone (4aZf) did not result in gene repression. Expression of weakly active 4aZf-HhaI mutant enzyme also failed to result in any significant gene repression (Fig. 5A) or methylation at any of the HhaI sites present within the target region above background (data not shown), in line with previous results for this enzyme (14Smith A.E. Ford K.G. Nucleic Acids Res. 2007; 35: 740-754Crossref PubMed Scopus (44) Google Scholar), and confirms the lack of general zinc finger fusion protein binding-induced effects in the absence of a fully functional Mtase component. To address issues relating to the possible contributions of reporter gene integration sites to de novo methylation-mediated gene repression, we performed CAT assays on pooled clonal populations harboring the integrated reporter vector (∼25 clones) that had been transfected with targeted Mtase and control vectors. Targeted Mtase expression induced a similar drop in gene expression levels to that of individual clones that were examined, suggesting no locus-specific bias toward gene repression (Fig. 5A). Given that intuitively, sites of integration are more likely to occur in euchromatic, i.e. normally transcriptionally active, regions of the genome, the demonstration of targeted methylation-mediated gene silencing at multiple regions of this type would suggest that this route for exogenous control of gene repression is robust. De Novo Methylation Initiates the Acquisition of a Repressive Histone Mark—Given the strong correlation historically observed between the methylation status of DNA and heterochromatin formation, we examined the chromatin composition associated with the target site/promoter region as a result of transient 4aZf-FH expression using chromatin immunoprecipitation analysis. Chromatin immunoprecipitation analysis of the promoter region showed that 4aZf-FH-targeted methylation was associated with a nearly 8-fold enrichment of histone H3K9me2 methylation (Fig. 6A), a histone modification known to be associated with transcriptional repression. This clearly pointed toward the initiation of a repressive histone mark for this region of DNA in response to de novo methylation. Similarly, analysis of histone H3K4me3, a marker for transcriptionally active chromatin (21Santos-Rosa H. Schneider R. Bannister A.J. Sherriff J. Bernstein B.E. Emre N.C. Schreiber S.L. Mellor J. Kouzarides T. Nature. 2002; 419: 407-411Crossref PubMed Scopus (1608) Google Scholar), showed a relative 2.5-fold reduction in response to 4aZf-FH expression compared with controls. There was no observable change in histone H3K9me2 or H3K4me3 in c-fos and afm gene promoters, which were examined as additional controls for the potential effects of any nontargeted background methylation on chromatin composition throughout the genome (Fig. 6B). It is widely accepted, mostly through the correlative observation that methylated genes in vivo ar" @default.
• W2046469884 created "2016-06-24" @default.
• W2046469884 creator A5013975946 @default.
• W2046469884 creator A5064398061 @default.
• W2046469884 creator A5070670737 @default.
• W2046469884 creator A5080966421 @default.
• W2046469884 creator A5083467513 @default.
• W2046469884 date "2008-04-01" @default.
• W2046469884 modified "2023-10-14" @default.
• W2046469884 title "Heritable Gene Repression through the Action of a Directed DNA Methyltransferase at a Chromosomal Locus" @default.
• W2046469884 cites W1486257535 @default.
• W2046469884 cites W1554534316 @default.
• W2046469884 cites W1567517848 @default.
• W2046469884 cites W1966288336 @default.
• W2046469884 cites W1966981147 @default.
• W2046469884 cites W1967725040 @default.
• W2046469884 cites W1977118826 @default.
• W2046469884 cites W1980449150 @default.
• W2046469884 cites W1982598173 @default.
• W2046469884 cites W1984807040 @default.
• W2046469884 cites W1985014165 @default.
• W2046469884 cites W1985634754 @default.
• W2046469884 cites W1995146753 @default.
• W2046469884 cites W1996926729 @default.
• W2046469884 cites W2008933729 @default.
• W2046469884 cites W2011480379 @default.
• W2046469884 cites W2014493475 @default.
• W2046469884 cites W2019616754 @default.
• W2046469884 cites W2022936129 @default.
• W2046469884 cites W2023687962 @default.
• W2046469884 cites W2035746042 @default.
• W2046469884 cites W2037541952 @default.
• W2046469884 cites W2058725026 @default.
• W2046469884 cites W2059479474 @default.
• W2046469884 cites W2063110349 @default.
• W2046469884 cites W2080620002 @default.
• W2046469884 cites W2090822519 @default.
• W2046469884 cites W2094643276 @default.
• W2046469884 cites W2097102074 @default.
• W2046469884 cites W2099067892 @default.
• W2046469884 cites W2099438292 @default.
• W2046469884 cites W2100325414 @default.
• W2046469884 cites W2110177085 @default.
• W2046469884 cites W2143522889 @default.
• W2046469884 cites W2145084579 @default.
• W2046469884 cites W2149469688 @default.
• W2046469884 cites W2155929363 @default.
• W2046469884 cites W2170686685 @default.
• W2046469884 cites W2210620858 @default.
• W2046469884 cites W4252890901 @default.
• W2046469884 doi "https://doi.org/10.1074/jbc.m710393200" @default.
• W2046469884 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18272522" @default.
• W2046469884 hasPublicationYear "2008" @default.
• W2046469884 type Work @default.
• W2046469884 sameAs 2046469884 @default.
• W2046469884 citedByCount "41" @default.
• W2046469884 countsByYear W20464698842012 @default.
• W2046469884 countsByYear W20464698842013 @default.
• W2046469884 countsByYear W20464698842014 @default.
• W2046469884 countsByYear W20464698842015 @default.
• W2046469884 countsByYear W20464698842016 @default.
• W2046469884 countsByYear W20464698842017 @default.
• W2046469884 countsByYear W20464698842018 @default.
• W2046469884 countsByYear W20464698842021 @default.
• W2046469884 crossrefType "journal-article" @default.
• W2046469884 hasAuthorship W2046469884A5013975946 @default.
• W2046469884 hasAuthorship W2046469884A5064398061 @default.
• W2046469884 hasAuthorship W2046469884A5070670737 @default.
• W2046469884 hasAuthorship W2046469884A5080966421 @default.
• W2046469884 hasAuthorship W2046469884A5083467513 @default.
• W2046469884 hasBestOaLocation W20464698841 @default.
• W2046469884 hasConcept C104317684 @default.
• W2046469884 hasConcept C150194340 @default.
• W2046469884 hasConcept C186310378 @default.
• W2046469884 hasConcept C2779979206 @default.
• W2046469884 hasConcept C33288867 @default.
• W2046469884 hasConcept C54355233 @default.
• W2046469884 hasConcept C552990157 @default.
• W2046469884 hasConcept C84597430 @default.
• W2046469884 hasConcept C86803240 @default.
• W2046469884 hasConcept C91965660 @default.
• W2046469884 hasConceptScore W2046469884C104317684 @default.
• W2046469884 hasConceptScore W2046469884C150194340 @default.
• W2046469884 hasConceptScore W2046469884C186310378 @default.
• W2046469884 hasConceptScore W2046469884C2779979206 @default.
• W2046469884 hasConceptScore W2046469884C33288867 @default.
• W2046469884 hasConceptScore W2046469884C54355233 @default.
• W2046469884 hasConceptScore W2046469884C552990157 @default.
• W2046469884 hasConceptScore W2046469884C84597430 @default.
• W2046469884 hasConceptScore W2046469884C86803240 @default.
• W2046469884 hasConceptScore W2046469884C91965660 @default.
• W2046469884 hasIssue "15" @default.
• W2046469884 hasLocation W20464698841 @default.
• W2046469884 hasOpenAccess W2046469884 @default.
• W2046469884 hasPrimaryLocation W20464698841 @default.
• W2046469884 hasRelatedWork W1828691184 @default.
• W2046469884 hasRelatedWork W1886625688 @default.
• W2046469884 hasRelatedWork W2028087115 @default.

• next